Sernova Corp
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Bio… Read more
Sernova Corp - Asset Resilience Ratio
Sernova Corp (SEOVF) has an Asset Resilience Ratio of 0.00% as of October 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Sernova Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Sernova Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Sernova Corp maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Sernova Corp Industry Peers by Asset Resilience Ratio
Compare Sernova Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Sernova Corp (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Sernova Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-10-31 | 0.00% | $0.00 | $7.53 Million | -- |
| 2023-10-31 | 50.14% | $11.08 Million | $22.11 Million | -37.51pp |
| 2022-10-31 | 87.64% | $46.00 Million | $52.48 Million | -- |
| 2021-10-31 | 0.00% | $0.00 | $29.82 Million | -- |
| 2020-10-31 | 0.00% | $0.00 | $5.73 Million | -- |
| 2019-10-31 | 36.04% | $2.01 Million | $5.57 Million | +8.19pp |
| 2018-10-31 | 27.85% | $1.00 Million | $3.61 Million | +5.78pp |
| 2017-10-31 | 22.07% | $1.00 Million | $4.55 Million | +10.82pp |
| 2016-10-31 | 11.24% | $700.00K | $6.23 Million | -73.40pp |
| 2015-10-31 | 84.64% | $2.67 Million | $3.15 Million | +11.23pp |
| 2014-10-31 | 73.41% | $2.62 Million | $3.57 Million | -1.89pp |
| 2013-10-31 | 75.30% | $4.51 Million | $5.99 Million | +9.14pp |
| 2012-10-31 | 66.16% | $4.11 Million | $6.21 Million | -- |